| Status: | Phase 3 |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| UNII: | 1PHP3QG5PZ |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Subtilisin/kexin type 9 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Cardiovascular Diseases | 3 | D002318 | ClinicalTrials |
| Hyperlipoproteinemia Type II | 3 | D006938 | ClinicalTrials |
| Hypercholesterolemia | 3 | D006937 | ClinicalTrials |
| Hyperlipoproteinemia Type II | 3 | D006938 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4650405 |
| FDA SRS | 1PHP3QG5PZ |
CONTENTS